Combined HSV-TK/GCV and secondary lymphoid tissue chemokine gene therapy inhibits tumor growth and elicits potent antitumor CTL response in tumor-bearing mice

Anticancer Research

Volumn 22, Issue 2 A, 2002, Pages 599-604

  Warren, Patrick ^a   Song, Wendy ^a   Holle, Eric ^a   Holmes, Lilia ^a   Wei, Yangzhang ^a   Li, Jin ^a   Wagner, Thomas ^a   Yu, Xianzhong ^a  

^a Oncology Research Institute   (United States)

Author keywords

Chemokine; CTL; HSV; Lymphoid tissue; Secondary; Thymidine kinase

Indexed keywords

CHEMOKINE; GANCICLOVIR; PRODRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER THERAPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE THERAPY; HERPES SIMPLEX VIRUS; IMMUNE RESPONSE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUICIDE GENE THERAPY; TUMOR GROWTH;

ANIMALS; ANTIGEN PRESENTATION; CELL DIVISION; CHEMOKINES, CC; DENDRITIC CELLS; GANCICLOVIR; GENE THERAPY; MELANOMA, EXPERIMENTAL; MICE; SIMPLEXVIRUS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; THYMIDINE KINASE;

EID: 0036244445     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Prodrug activation enzymes in cancer gene therapy
2. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control study
3. The "bystander effect": Tumor regression when a fraction of tumor mass is genetically modified
4. Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells
5. Gap junctions play a role in the "bystander effect" of the Herpes simplex virus thymidine kinase/ganciclovir system in vitro
6. A "distant" bystander effect of suicide gene therapy: Regression of non-transduced tumors together with a distant transduced tumor
7. The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase (HSVtk) gene is dependent on connexin expression and cell communication via gap junctions
8. Inhibition of establishment of hepatic metastasis in mice by combination gene therapy using both herpes simplex virus thymidine kinase and granulocyte macrophage-colony stimulating factor genes in murine colon cancer
9. Combination therapy with suicide and cytokine genes for hepatic metastases of lung cancer
10. Dendritic cells and the control of immunity
11. The outline structure of the T-cell alpha beta receptor
12. Mapping T-cell receptorpeptide contacts by variant peptide immunization of single-chain transgenics
13. Predicted complementarity determining regions of the T cell antigen receptor determine antigen specificity
14. Dendritic cell vaccination for cancer therapy
15. Human chemokines: An update
16. Chemokines and chemokine receptors in T-cell development
17. The CC chemokine receptor-7ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells
18. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites
19. A lymphocyte-specific CC chemokine, secondary lymphoid tissue chemokine (SLC), is a highly efficient chemoattractant for B cells and activated T cells
20. CCR7 ligands, SLC/6Ckine/Exodus2/TCA4 and CKbeta-11/MIP-3beta/ELC, are chemoattractants for CD56(+) CD16(-) NK cells and late stage lymphoid progenitors
21. Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo
22. Antitumor effects of the mouse chemokine 6ckine/SLC through angiostatic and immunological mechanisms
23. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
24. Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component
25. Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer
26. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene
27. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy
28. Mechanism of 'bystander effect' killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment
29. Ganciclovir chemoablation of herpes thymidine kinase suicide gene-modified tumors produces tumor necrosis and induces systemic immune responses
30. Combination gene therapy for liver metastasis of colon carcinoma in vivo